|
시장보고서
상품코드
1360069
남미의 인공심폐 시장 예측(-2028년) : 지역별 분석 - 제품, 용도, 유형, 연령층, 최종 용도별South America Cardiopulmonary Oxygenator Market Forecast to 2028 -Regional Analysis - by Product, Application, Type, Age Group, and End Use |
||||||
남미의 인공심폐 시장은 2022년에 4,413만 달러로 평가되며, 2028년에는 5,349만 달러에 달할 것으로 예측되고 있습니다. 2022-2028년의 CAGR은 3.3%로 추정됩니다.
고령화에 수반하는 외과수술의 증가가 남미의 인공심폐 시장을 활성화
수술은 심혈관 질환이나 폐 질환과 같은 건강 상태를 관리하기 위해 필요합니다. 일부 의료 사례의 경우 수술 없이는 다른 대안이 효과가 없습니다. 심혈관 수술에 대한 높은 수요는 고령화 사회에서 심혈관 질환의 이환율이 증가했기 때문일 수 있습니다. 또한 폐 이식은 심각한 폐 손상이나 COVID-19와 관련된 호흡 부전이 치유되지 않는 환자에게는 유일한 유용한 치료법일 수 있습니다. 이처럼 심혈관 및 폐 이식 수술이 증가함에 따라 이 지역의 심폐 산소 공급 장비에 대한 수요도 증가하는 추세입니다.
WHO에 따르면 60세 이상 노인의 비율은 2015년 12%에서 2050년에는 22%에 달할 것으로 추정됩니다. 심혈관 질환은 65세 이상 성인의 사망 원인 중 1위를 차지합니다. 노화는 심장과 혈관에 변화를 가져와 이러한 질병의 발병 위험을 높입니다. 따라서 노인 인구의 심혈관 질환의 유행은 인공 심폐 시장의 성장에 기여하고 있습니다.
남미 인공 심폐 시장 개요
남미 인공심폐 시장은 브라질, 아르헨티나, 기타 남미로 구분됩니다. 브라질은 기타 지역에 비해 의료 시설과 서비스가 잘 갖추어져 있습니다. 브라질은 세계에서 가장 빠르게 고령화되는 국가로 2020년에는 노인 인구가 3,010만 명으로 전체 인구의 14.3%를 차지할 것으로 예상됩니다. 또한 브라질 통계협회에 따르면 2050년까지 65세 이상 노인 인구는 36%에 달할 것으로 예상됩니다. 고령화는 특발성 폐섬유증, 만성폐쇄성폐질환과 같은 폐질환 등 다양한 만성질환에 대한 취약성을 높입니다. 브라질의 노인 인구가 증가함에 따라 호흡기 질환과 같은 다양한 건강 질환의 발생률이 증가하여 호흡기 흡입기에 대한 수요 증가로 이어질 것입니다. 인구 고령화로 인해 질병 발생률이 증가하며, Instituto Nacional de Estadistica y Censos, INDEC에 따르면 2020년에는 아르헨티나 인구의 15.7%, 약 710만 명이 60세 이상이 될 것으로 예상합니다. 또한 2050년에는 22%(약 1,250만 명), 2100년에는 34%(약 2,000만 명)에 달할 것으로 추정됩니다.
또한 지역 주민의 약 1/3이 무료 공공 의료 서비스를 받고 있으며, 민간 또는 공공 보험 의료 기관이 3분의 2를 담당하고 있습니다. 또한 급성 심혈관 질환의 진단에 대한 인식률이 50-60%로 매우 낮습니다. 이에 아르헨티나 심방세동 협회는 심방세동(AF)에 대한 정보, 지원, 기존 치료법, 새로운 치료법 및 혁신적인 치료법에 대한 접근성을 제공하기 위해 설립되었습니다.
남미 인공심폐 시장 매출 및 2028년까지의 예측(금액)
남미 인공 심폐 시장 세분화
남미 인공심폐 시장은 제품, 용도, 유형, 연령대, 최종 용도, 국가별로 세분화됩니다. 제품별로는 멤브레인형 산소 흡입기와 기포형 산소 흡입기로 나뉘며, 2022년 멤브레인형 산소 흡입기 시장 점유율이 더 클 것으로 예상됩니다.
용도별로는 심장용과 호흡기용으로 나뉘며, 2022년에는 심장용이 시장 점유율이 더 큽니다. 또한 심장은 급성 심근경색, 심근염, 이식 후 합병증, 보상성 심근증, 기타로 구분됩니다. 또한 호흡기는 호흡부전, 급성 호흡곤란 증후군, 폐색전증, 폐렴, COVID-19 등으로 세분화됩니다.
유형별로 보면 시장은 재사용 가능한 인공심폐와 일회용 인공심폐로 나뉘며, 2022년 시장 점유율은 재사용 가능한 인공심폐가 더 큽니다.
연령대별로 보면 시장은 성인, 소아, 신생아로 나뉩니다. 성인은 2022년에 가장 큰 시장 점유율을 차지했습니다.
최종 사용처에 따라 시장은 병원 및 클리닉, 외래수술센터(ASC), 기타로 구분되며, 2022년 시장 점유율은 병원 및 클리닉이 가장 큰 비중을 차지합니다.
국가별로는 시장은 브라질, 아르헨티나, 기타 남미로 구분됩니다. 2022년의 시장 점유율은 브라질이 압도적이었습니다.
Getinge AB, LivaNova Plc, Medtronic Plc, Terumo Corp, Nipro Medical Corp, Microport Scientific Corp, Braile Biomedica Industry, Commerce and Representation Ltd, Chalice Medical Ltd, Fresenius Medical Care AG &Co KGaA가 이 지역의 인공심폐 시장에서 사업을 운영하고 있는 주요 기업입니다.
목차
제1장 서론
제2장 남미의 인공심폐 시장 - 요점
제3장 조사 방법
- 조사 범위
- 2차 조사
- 1차 조사
제4장 남미의 인공심폐 시장 구도
- PEST 분석
- 남미의 PEST 분석
- 전문가의 견해
제5장 남미의 인공심폐 시장 - 주요 시장 역학
- 시장 촉진요인
- 심폐 질환의 발생률 증가
- 고령화에 수반하는 외과수술의 증가
- 시장 억제요인
- 숙련 전문가의 부족
- 시장 기회
- 소아 및 신생아 환자에서 인공심폐의 사용 증가
- 향후 동향
- 폐이식술에서 휴대용 체외식막산소화의 사용
- 영향 분석
제6장 인공심폐 시장 - 남미 분석
- 남미의 인공심폐 시장 매출과 예측 분석
제7장 남미의 인공심폐 시장 - 2028년까지의 매출과 예측 - 제품별
- 인공심폐 시장의 제품별 매출 점유율(2021년·2028년)
- 막식 산소 공급기
- 버블식 산소 공급기
제8장 남미의 인공심폐 시장 - 용도별 매출과 2028년까지의 예측
- 인공심폐 시장 2021년 및 2028년 유형별 판매고 점유율(%)
- 심장용
- 호흡기
제9장 남미의 인공심폐 시장 분석과 2028년까지의 예측 - 유형별
- 인공심폐 시장 : 유형별 2021년·2028년(%)
- 재이용형 산소 공급기
- 일회용 산소 공급기
제10장 남미의 인공심폐 시장 분석과 2028년까지의 예측 : 연령층별
- 인공심폐 시장 : 연령층별 2021년·2028년(%)
- 성인
- 소아
- 신생아
제11장 남미의 인공심폐 시장 : 최종 사용별 매출과 2028년까지의 예측
- 인공심폐 시장 최종 사용별 매출 점유율(2021년·2028년)
- 병원 및 진료소
- 외래 수술 센터
- 기타
제12장 남미의 인공심폐 시장 : 매출과 2028년까지의 예측 : 국가별 분석
제13장 남미의 인공심폐 시장 - 업계 상황
- 인공심폐 시장의 성장 전략
- 유기적 성장 전략
- 무기적 성장 전략
제14장 기업 개요
- Getinge AB
- LivaNova Plc
- Medtronic Plc
- Terumo Corp
- Nipro Medical Corp
- MicroPort Scientific Corp
- Braile Biomedica Industry, Commerce and Representations Ltd
- Chalice Medical Ltd
- Fresenius Medical Care AG & Co KGaA
제15장 부록
KSA 23.10.19The South America cardiopulmonary oxygenator market was valued at US$ 44.13 million in 2022 and is expected to reach US$ 53.49 million by 2028. It is estimated to register a CAGR of 3.3 % from 2022 to 2028.
Increasing Surgical Procedures with Surging in Aging Population is Fueling South America Cardiopulmonary Oxygenator Market
Surgical procedures are necessary for managing health conditions such as cardiovascular diseases and lung disorders. In some medical cases, no alternative works without surgery. The high demand for cardiovascular surgeries can be attributed to the increase in the incidence of cardiovascular diseases in the aging population. Further, lung transplantation may be the only helpful treatment option for patients experiencing serious lung damage and non-resolving COVID-19-associated respiratory failure. Thus, with the growing number of cardiovascular and lung transplant surgeries, the demand for cardiopulmonary oxygenators is also on the rise in the region.
According to the WHO, the percentage of people aged 60 and above is estimated to reach 22% by 2050 from 12% in 2015. Cardiovascular diseases continue to be the leading cause of death among adults over the age of 65. Aging can cause changes in the heart and blood vessels, increasing the risk of developing these diseases. Therefore, the prevalence of cardiovascular diseases among geriatric populations is contributing to the growth of the cardiopulmonary oxygenators market.
South America Cardiopulmonary Oxygenator Market Overview
The South America cardiopulmonary oxygenator market is segmented into Brazil, Argentina, and the Rest of South & Central America. The healthcare facilities and services are better in the country compared to the other countries in the region. It has been experiencing the fastest demographic aging worldwide. In 2020, the geriatric population accounted for 30.1 million, ~14.3% of the total population. Further, as per the Brazil Statistical Institute, people aged 65 and over are expected to reach 36% by 2050. Aging increases vulnerability to various chronic diseases, such as lung disorders, including idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease, which have become more common among older people. As the geriatric population in Brazil grows, it leads to an increased incidence of various health illnesses, such as respiratory diseases, leading to increased demand for respiratory inhalers. The aging population results in increased incidences of diseases. According to Instituto Nacional de Estadistica y Censos, INDEC, in 2020, 15.7% of Argentina's population was over age 60, or almost 7.1 million people. And is estimated to continue to rise to 22% by 2050, which will be equivalent to around 12.5 million people, and will reach 34% by 2100, approximately 20 million individuals.
Moreover, approximately one-third of the community receives free public health services, and private or institutional insurance healthcare providers cover two-third of the siders. Additionally, the awareness rate for medical diagnosis of acute cardiovascular disease is low, between 50% to 60%. Therefore, an AF Association was started in Argentina that provide information, support, and access to established, new or innovative treatments for Atrial Fibrillation (AF) in the region
South America Cardiopulmonary Oxygenator Market Revenue and Forecast to 2028 (US$ Million)
South America Cardiopulmonary Oxygenator Market Segmentation
The South America cardiopulmonary oxygenator market is segmented into product, application, type, age group, end use, and country. Based on product, the market is bifurcated into membrane oxygenator and bubble oxygenator. The membrane oxygenator segment held a larger market share in 2022.
Based on application, the market is bifurcated into cardiac and respiratory. The cardiac segment held a larger market share in 2022. Further, cardiac is segmented into acute myocardial infarction, myocarditis, post-transplant complications, decompensated cardiomyopathy, and others. Further, respiratory is segmented into respiratory failure, acute respiratory distress syndrome, pulmonary embolism, pneumonia, and COVID-19.
Based on type, the market is bifurcated into reusable cardiopulmonary oxygenators and disposable cardiopulmonary oxygenators. The reusable cardiopulmonary oxygenators segment held a larger market share in 2022.
Based on age group, the market is segmented into adults, pediatric, and neonates. The adults segment held the largest market share in 2022.
Based on end use, the market is segmented into hospitals and clinics, ambulatory surgical centers, and others. The hospitals and clinics segment held the largest market share in 2022.
Based on country, the market is segmented into Brazil, Argentina, and the Rest of South America. Brazil dominated the market share in 2022.
Getinge AB; LivaNova Plc; Medtronic Plc; Terumo Corp; Nipro Medical Corp; Microport Scientific Corp; Braile Biomedica Industry, Commerce and Representation Ltd; Chalice Medical Ltd; and Fresenius Medical Care AG & Co KGaA are the leading companies operating in the cardiopulmonary oxygenator market in the region.
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South America Cardiopulmonary Oxygenator market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in South America Cardiopulmonary Oxygenator market, thereby allowing players across the value chain to develop effective long-term strategies
- develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth South America market trends and outlook coupled with the factors driving the Cardiopulmonary Oxygenator market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Table Of Contents
1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 South America Cardiopulmonary Oxygenator Market - by Product
- 1.3.2 South America Cardiopulmonary Oxygenator Market - by Application
- 1.3.3 South America Cardiopulmonary Oxygenator Market - by Type
- 1.3.4 South America Cardiopulmonary Oxygenator Market - by Age Group
- 1.3.5 South America Cardiopulmonary Oxygenator Market - by End Use
- 1.3.6 South America Cardiopulmonary Oxygenator Market - by Country
2. South America Cardiopulmonary Oxygenator Market - Key Takeaways
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. South America Cardiopulmonary Oxygenator Market - Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.2.1 South America PEST Analysis
- 4.3 Expert's Opinion
5. South America Cardiopulmonary Oxygenators Market - Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Rise in Incidence of Cardiopulmonary Diseases
- 5.1.2 Increasing Surgical Procedures with Surging in Aging Population
- 5.2 Market Restraints
- 5.2.1 Lack of Skilled Professionals
- 5.3 Market Opportunities
- 5.3.1 Increasing Usage of Cardiopulmonary Oxygenators in Pediatric and Neonatal Patients
- 5.4 Future Trends
- 5.4.1 Use of Portable Extracorporeal Membrane Oxygenation in Lung Transplant Procedures
- 5.5 Impact Analysis
6. Cardiopulmonary Oxygenators Market - South America Analysis
- 6.1 South America Cardiopulmonary Oxygenators Market Revenue Forecast and Analysis
7. South America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by Product
- 7.1 Overview
- 7.2 Cardiopulmonary Oxygenators Market Revenue Share, by Product 2021 & 2028 (%)
- 7.3 Membrane Oxygenator
- 7.3.1 Overview
- 7.3.2 Membrane Oxygenator: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4 Bubble Oxygenator
- 7.4.1 Overview
- 7.4.2 Bubble Oxygenator: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
8. South America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by Application
- 8.1 Overview
- 8.2 Cardiopulmonary Oxygenators Market Revenue Share, by Type 2021 & 2028 (%)
- 8.3 Cardiac
- 8.3.1 Overview
- 8.3.2 Cardiac: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 8.3.3 Acute myocardial infarction
- 8.3.4 Overview
- 8.3.5 Acute myocardial infarction: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 8.3.6 Myocarditis
- 8.3.7 Overview
- 8.3.8 Myocarditis: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 8.3.9 Post-transplant complication
- 8.3.10 Overview
- 8.3.11 Post-transplant complication: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 8.3.12 Decompensated Cardiomyopathy
- 8.3.13 Overview
- 8.3.14 Decompensated Cardiomyopathy: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 8.3.15 Others
- 8.3.16 Overview
- 8.3.17 Others: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 8.4 Respiratory
- 8.4.1 Overview
- 8.4.2 Respiratory: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 8.4.3 Respiratory Failure
- 8.4.4 Overview
- 8.4.5 Respiratory Failure: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 8.4.6 Acute Respiratory Distress Syndrome
- 8.4.7 Overview
- 8.4.8 Acute Respiratory Distress Syndrome: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 8.4.9 Pulmonary Embolism
- 8.4.10 Overview
- 8.4.11 Pulmonary Embolism: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 8.4.12 Pneumonia
- 8.4.13 Overview
- 8.4.14 Pneumonia: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 8.4.15 COVID-19
- 8.4.16 Overview
- 8.4.17 COVID-19: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
9. South America Cardiopulmonary Oxygenators Market Analysis and Forecast to 2028 - by Type
- 9.1 Overview
- 9.2 Cardiopulmonary Oxygenators Market, by Type 2021 & 2028 (%)
- 9.3 Reusable Oxygenator
- 9.3.1 Overview
- 9.3.2 Reusable Oxygenator: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 9.4 Disposable Oxygenator
- 9.4.1 Overview
- 9.4.2 Disposable Oxygenator: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
10. South America Cardiopulmonary Oxygenators Market Analysis and Forecast to 2028 - by Age Group
- 10.1 Overview
- 10.2 Cardiopulmonary Oxygenators Market, by Age Group 2021 & 2028 (%)
- 10.3 Adults
- 10.3.1 Overview
- 10.3.2 Adults: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 10.4 Pediatric
- 10.4.1 Overview
- 10.4.2 Pediatric: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 10.5 Neonates
- 10.5.1 Overview
- 10.5.2 Neonates: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
11. South America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by End Use
- 11.1 Overview
- 11.2 Cardiopulmonary Oxygenators Market Revenue Share, by End Use 2021 & 2028 (%)
- 11.3 Hospitals and Clinics
- 11.3.1 Overview
- 11.3.2 Hospitals and Clinics: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 11.4 Ambulatory Surgical Centers
- 11.4.1 Overview
- 11.4.2 Ambulatory Surgical Centers: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 11.5 Others
- 11.5.1 Overview
- 11.5.2 Others: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
12. South America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by Country Analysis
- 12.1 South America Cardiopulmonary Oxygenators Market
- 12.1.1 Overview
- 12.1.1.1 Brazil: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 12.1.1.1.1 Overview
- 12.1.1.1.2 Brazil: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 12.1.1.1.3 Brazil: Cardiopulmonary Oxygenators Market, by Product, 2019-2028 (USD Million)
- 12.1.1.1.4 Brazil: Cardiopulmonary Oxygenators Market, by Application, 2019-2028 (USD Million)
- 12.1.1.1.4.1 Brazil: Cardiopulmonary Oxygenators Market, by Cardiac Application, 2019-2028 (USD Million)
- 12.1.1.1.4.2 Brazil: Cardiopulmonary Oxygenators Market, by Respiratory Application, 2019-2028 (USD Million)
- 12.1.1.1.5 Brazil: Cardiopulmonary Oxygenators Market, by Type, 2019-2028 (USD Million)
- 12.1.1.1.6 Brazil: Cardiopulmonary Oxygenators Market, by Age Group, 2019-2028 (USD Million)
- 12.1.1.1.7 Brazil: Cardiopulmonary Oxygenators Market, by End Use, 2019-2028 (USD Million)
- 12.1.1.2 Argentina: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 12.1.1.2.1 Overview
- 12.1.1.2.2 Argentina: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 12.1.1.2.3 Argentina: Cardiopulmonary Oxygenators Market, by Product, 2019-2028 (USD Million)
- 12.1.1.2.4 Argentina: Cardiopulmonary Oxygenators Market, by Application, 2019-2028 (USD Million)
- 12.1.1.2.4.1 Argentina: Cardiopulmonary Oxygenators Market, by Cardiac Application, 2019-2028 (USD Million)
- 12.1.1.2.4.2 Argentina: Cardiopulmonary Oxygenators Market, by Respiratory Application, 2019-2028 (USD Million)
- 12.1.1.2.5 Argentina: Cardiopulmonary Oxygenators Market, by Type, 2019-2028 (USD Million)
- 12.1.1.2.6 Argentina: Cardiopulmonary Oxygenators Market, by Age Group, 2019-2028 (USD Million)
- 12.1.1.2.7 Argentina: Cardiopulmonary Oxygenators Market, by End Use, 2019-2028 (USD Million)
- 12.1.1.3 Rest of South America: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 12.1.1.3.1 Overview
- 12.1.1.3.2 Rest of South America: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 12.1.1.3.3 Rest of South America: Cardiopulmonary Oxygenators Market, by Product, 2019-2028 (USD Million)
- 12.1.1.3.4 Rest of South America: Cardiopulmonary Oxygenators Market, by Application, 2019-2028 (USD Million)
- 12.1.1.3.4.1 Rest of South America: Cardiopulmonary Oxygenators Market, by Cardiac Application, 2019-2028 (USD Million)
- 12.1.1.3.4.2 Rest of South America: Cardiopulmonary Oxygenators Market, by Respiratory Application, 2019-2028 (USD Million)
- 12.1.1.3.5 Rest of South America: Cardiopulmonary Oxygenators Market, by Type, 2019-2028 (USD Million)
- 12.1.1.3.6 Rest of South America: Cardiopulmonary Oxygenators Market, by Age Group, 2019-2028 (USD Million)
- 12.1.1.3.7 Rest of South America: Cardiopulmonary Oxygenators Market, by End Use, 2019-2028 (USD Million)
- 12.1.1.1 Brazil: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 12.1.1 Overview
13. South America Cardiopulmonary Oxygenators Market-Industry Landscape
- 13.1 Overview
- 13.2 Growth Strategies in Cardiopulmonary Oxygenator Market
- 13.3 Organic Growth Strategies
- 13.3.1 Overview
- 13.4 Inorganic Growth Strategies
- 13.4.1 Overview
14. Company Profiles
- 14.1 Getinge AB
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
- 14.2 LivaNova Plc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
- 14.3 Medtronic Plc
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
- 14.4 Terumo Corp
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
- 14.5 Nipro Medical Corp
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
- 14.6 MicroPort Scientific Corp
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
- 14.7 Braile Biomedica Industry, Commerce and Representations Ltd
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.8 Chalice Medical Ltd
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
- 14.9 Fresenius Medical Care AG & Co KGaA
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
15. Appendix
- 15.1 About The Insight Partners
- 15.2 Glossary of Terms
